title: Synthesis, characterization and antimicrobial investigation of some moxifloxacin metal complexes.
abstract: The new complexes of moxifloxacin (MOX), with Ti(IV), Y(III), Pd(II) and Ce(IV) have been synthesized. These complexes were then characterized by melting point, magnetic studies and spectroscopic techniques involving infrared spectra (IR), UV-Vis, (1)H NMR. C, H, N and halogen elemental analysis and thermal behavior of complexes also investigated. The results suggested that the molar ratio for all complexes is M: MOX=1:2 where moxifloxacin acts as a bidentate via one of the oxygen atoms of the carboxylate group and through the ring carbonyl group and the complexes have the following formula [Ti(MOX)(2)](SO(4))(2)·7H(2)O, [Y(MOX)(2)Cl(2)]Cl·12H(2)O, [Pd(MOX)(2)(H(2)O)(2)]Cl(2)·6H(2)O and [Ce(MOX)(2)](SO(4))(2)·2H(2)O. The activation energies, E*, enthalpies, ΔH*, entropies, ΔS* and Gibbs free energies, ΔG*, of the thermal decomposition reactions have been derived from thermogravimetric (TGA) and differential thermogravimetric (DrTG) curves, using Coats-Redfern (CR) and Horowitz-Metzger (HM) methods. The antimicrobial activity of these complexes has been evaluated against three Gram-positive and three Gram-negative bacteria and compared with the reference drug moxifloxacin. The antibacterial activity of Ti(IV) complex is significant for E. coli K32 and highly significant for S. aureus K1, B. subtilis K22, Br. otitidis K76, P. aeruginosa SW1 and K. oxytoca K42 compared with free moxifloxacin.
authors.affiliation: Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt. sadeek59@yahoo.com
authors.forename: Sadeek A
authors.initials: SA
authors.lastname: Sadeek
authors.forename: Walaa H
authors.initials: WH
authors.lastname: El-Shwiniy
authors.forename: Mohamed S
authors.initials: MS
authors.lastname: El-Attar
mesh_terms: D000890:Anti-Infective Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D001372:Aza Compounds / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D056831:Coordination Complexes / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D004583:Electrons; D024841:Fluoroquinolones; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D011804:Quinolines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet; D013696:Temperature; D013818:Thermogravimetry
chemical_list: D000890:Anti-Infective Agents; D001372:Aza Compounds; D056831:Coordination Complexes; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin